J4

• • 上一篇    下一篇

口服降糖药曲格列酮的核磁共振谱学表征

尹建元1,,王恩思1,2   

  1. 1.吉林大学药学院,长春,130021; 2.吉林大学生命科学学院,长春,130023
  • 收稿日期:2002-05-28 修回日期:1900-01-01
  • 通讯作者: 王恩思

Nuclear Magnetic Resonance Characterization of Oral Hypoglycemic Drug Troglitazone

YIN Jian-yuan1,WANG En-si1,2   

  1. 1. College of Pharmacy , Jilin University , Changchun 130021 , China ;2. College of Life Science , Jilin University , Changchun 130023 , China
  • Received:2002-05-28 Revised:1900-01-01
  • Contact: WANG En-si

摘要: 利用NMR,IR,UV及MS等实验技术研究了胰岛素增敏剂曲格列酮的波谱学特征.结合DEPT谱及1H-1H COSY 13C-1H HETCOSY,13C-1H LC-HETCOSY对曲格列酮的氢谱和碳谱进行完全归属.

关键词: 抗糖尿病药物, 曲格列酮, 核磁共振

Abstract: The NMR spectra are reported for troglitazone (5-[[4-[(6-hydroxy-2 ,5 ,7 ,8-tetramethyl-3 ,4-dihydrobenzopyran-2-yl-) methoxy ] pheny1 ] methy1] 2,4-thiazolidinedione) that is used as an oral hypoglycemic drug. By using DEPT , 1H-1H COSY , 13C-1H HETCOSY and 13C-1H LC-HETCOSY techniques along with IR , UV and MS , the proton and 13C spectra of troglitazone are assigned completely. This result also provides a basis analysis for the NMR characterization of the similar new drugs.

Key words: hypoglycemic drug, troglitazone, nuclear magnetic resonance

中图分类号: 

  • O656.4